Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.

Current yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerg...

Full description

Bibliographic Details
Main Authors: Douglas V Dolfi, Kathleen D Mansfield, Raj K Kurupati, Senthil Kannan, Susan A Doyle, Hildegund C J Ertl, Kenneth E Schmader, E John Wherry
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3796569?pdf=render
id doaj-f6e91471e32d431baab54f6c858f932d
record_format Article
spelling doaj-f6e91471e32d431baab54f6c858f932d2020-11-25T02:23:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7716410.1371/journal.pone.0077164Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.Douglas V DolfiKathleen D MansfieldRaj K KurupatiSenthil KannanSusan A DoyleHildegund C J ErtlKenneth E SchmaderE John WherryCurrent yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerging pandemic influenza virus strains to include in the vaccines. Thus, there has been considerable emphasis on understanding broadly protective immunological mechanisms for influenza virus. Recent studies have implicated memory CD4 T cells in heterotypic immunity in animal models and in human challenge studies. Here we examined how influenza virus vaccination boosted CD4 T cell responses in younger versus aged humans. Our results demonstrate that while the magnitude of the vaccine-induced CD4 T cell response and number of subjects responding on day 7 did not differ between younger and aged subjects, fewer aged subjects had peak responses on day 14. While CD4 T cell responses were inefficiently boosted against NA, both HA and especially nucleocaspid protein- and matrix-(NP+M) specific responses were robustly boosted. Pre-existing CD4 T cell responses were associated with more robust responses to influenza virus NP+M, but not H1 or H3. Finally pre-existing strain-specific NAb decreased the boosting of CD4 T cell responses. Thus, accumulation of pre-existing influenza virus-specific immunity in the form of NAb and cross-reactive T cells to conserved virus proteins (e.g. NP and M) over a lifetime of exposure to infection and vaccination may influence vaccine-induced CD4 T cell responses in the aged.http://europepmc.org/articles/PMC3796569?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Douglas V Dolfi
Kathleen D Mansfield
Raj K Kurupati
Senthil Kannan
Susan A Doyle
Hildegund C J Ertl
Kenneth E Schmader
E John Wherry
spellingShingle Douglas V Dolfi
Kathleen D Mansfield
Raj K Kurupati
Senthil Kannan
Susan A Doyle
Hildegund C J Ertl
Kenneth E Schmader
E John Wherry
Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
PLoS ONE
author_facet Douglas V Dolfi
Kathleen D Mansfield
Raj K Kurupati
Senthil Kannan
Susan A Doyle
Hildegund C J Ertl
Kenneth E Schmader
E John Wherry
author_sort Douglas V Dolfi
title Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
title_short Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
title_full Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
title_fullStr Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
title_full_unstemmed Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
title_sort vaccine-induced boosting of influenza virus-specific cd4 t cells in younger and aged humans.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Current yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerging pandemic influenza virus strains to include in the vaccines. Thus, there has been considerable emphasis on understanding broadly protective immunological mechanisms for influenza virus. Recent studies have implicated memory CD4 T cells in heterotypic immunity in animal models and in human challenge studies. Here we examined how influenza virus vaccination boosted CD4 T cell responses in younger versus aged humans. Our results demonstrate that while the magnitude of the vaccine-induced CD4 T cell response and number of subjects responding on day 7 did not differ between younger and aged subjects, fewer aged subjects had peak responses on day 14. While CD4 T cell responses were inefficiently boosted against NA, both HA and especially nucleocaspid protein- and matrix-(NP+M) specific responses were robustly boosted. Pre-existing CD4 T cell responses were associated with more robust responses to influenza virus NP+M, but not H1 or H3. Finally pre-existing strain-specific NAb decreased the boosting of CD4 T cell responses. Thus, accumulation of pre-existing influenza virus-specific immunity in the form of NAb and cross-reactive T cells to conserved virus proteins (e.g. NP and M) over a lifetime of exposure to infection and vaccination may influence vaccine-induced CD4 T cell responses in the aged.
url http://europepmc.org/articles/PMC3796569?pdf=render
work_keys_str_mv AT douglasvdolfi vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT kathleendmansfield vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT rajkkurupati vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT senthilkannan vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT susanadoyle vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT hildegundcjertl vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT kennetheschmader vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
AT ejohnwherry vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans
_version_ 1724858436632444928